D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
Walt Disney
DIS
|
+$410M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$386M |
| 4 |
GE Aerospace
GE
|
+$196M |
| 5 |
Dell
DELL
|
+$188M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$374M |
| 2 |
PayPal
PYPL
|
+$289M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$278M |
| 4 |
Nike
NKE
|
+$227M |
| 5 |
Amgen
AMGN
|
+$217M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.11% |
| 2 | Technology | 10.75% |
| 3 | Financials | 9.5% |
| 4 | Consumer Discretionary | 9.17% |
| 5 | Industrials | 7.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
CALL
Royal Gold
RGLD
$17.1B
| $774K | ﹤0.01% |
10,000
| – | – |
|
2527
Glaukos
GKOS
$8.92B
| $773K | ﹤0.01% |
20,486
+3,361
| +20% | +$111K |
|
2528
Box
BOX
$4.18B
| $772K | ﹤0.01% |
+49,006
| New | +$621K |
|
|
FARO
2529
DELISTED
Faro Technologies
FARO
| $772K | ﹤0.01% |
+21,485
| New | +$729K |
|
2530
Travere Therapeutics
TVTX
$5.27B
| $772K | ﹤0.01% |
34,500
-9,686
| -22% | -$184K |
|
|
RDUS
2531
DELISTED
Radius Recycling
RDUS
| $771K | ﹤0.01% |
36,911
-5,306
| -13% | -$101K |
|
|
MTOR
2532
DELISTED
MERITOR, Inc.
MTOR
| $767K | ﹤0.01% |
68,869
-48,984
| -42% | -$477K |
|
2533
CALL
Pan American Silver
PAAS
$18.6B
| $763K | ﹤0.01% |
43,300
+3,100
| +8% | +$58K |
|
2534
Verastem
VSTM
$534M
| $762K | ﹤0.01% |
47,720
+3,634
| +8% | +$58.5K |
|
2535
CALL
Lands' End
LE
$375M
| $758K | ﹤0.01% |
+52,300
| New | +$866K |
|
|
XENT
2536
DELISTED
Intersect ENT, Inc
XENT
| $757K | ﹤0.01% |
+47,760
| New | +$719K |
|
2537
PUT
HCA Healthcare
HCA
$86.4B
| $756K | ﹤0.01% |
10,000
| – | – |
|
2538
UNIFI
UFI
$121M
| $756K | ﹤0.01% |
25,695
-9,279
| -27% | -$253K |
|
2539
CACI
CACI
$11B
| $754K | ﹤0.01% |
7,475
+3,347
| +81% | +$323K |
|
|
ARIA
2540
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $754K | ﹤0.01% |
55,072
+43,129
| +361% | +$433K |
|
2541
Artisan Partners
APAM
$2.86B
| $751K | ﹤0.01% |
27,608
+2,314
| +9% | +$63.2K |
|
2542
PUT
Royal Caribbean
RCL
$81.8B
| $750K | ﹤0.01% |
10,000
-3,800
| -28% | -$268K |
|
2543
CALL
Welltower
WELL
$175B
| $748K | ﹤0.01% |
10,000
| – | – |
|
2544
Travelzoo
TZOO
$105M
| $746K | ﹤0.01% |
58,124
-14,851
| -20% | -$166K |
|
|
ZGNX
2545
DELISTED
Zogenix, Inc.
ZGNX
| $745K | ﹤0.01% |
65,214
-9,213
| -12% | -$85K |
|
2546
TC Energy
TRP
$71.2B
| $744K | ﹤0.01% |
15,634
-33,824
| -68% | -$1.58M |
|
|
DL
2547
DELISTED
China Distance Education Holdings Limited
DL
| $744K | ﹤0.01% |
57,567
+8,562
| +17% | +$96.3K |
|
|
NBL
2548
PUT
DELISTED
Noble Energy, Inc.
NBL
| $743K | ﹤0.01% |
20,800
| – | – |
|
|
HAYN
2549
CALL
DELISTED
Haynes International, Inc.
HAYN
| $742K | ﹤0.01% |
20,000
| – | – |
|
|
HAYN
2550
PUT
DELISTED
Haynes International, Inc.
HAYN
| $742K | ﹤0.01% |
20,000
| – | – |
|
Similar funds
D.E. Shaw & Co's Q3 2016 Portfolio in Review
As of Q3 2016, D.E. Shaw & Co held 3,773 positions worth $56.7B, up 4.5% from $54.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q3 2016 filing shows 448 new, 1,212 increased, 1,374 reduced and 429 closed positions. Its largest new stake was Dell: 13,808,231 shares worth $185M. The largest sale was Meta Platforms (Facebook), an estimated $374M.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 11% a quarter earlier, followed by Technology and Financials.
- D.E. Shaw & Co's largest Q3 2016 buy was Dell: 13,808,231 shares worth $185M.
- D.E. Shaw & Co added most to Apple in Q3 2016, an estimated $453M increase.
- D.E. Shaw & Co's biggest Q3 2016 reduction was Meta Platforms (Facebook), cutting an estimated $374M.
- D.E. Shaw & Co fully exited EMC CORPORATION in Q3 2016, selling an estimated $278M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $56.7B portfolio in Q3 2016.
- D.E. Shaw & Co opened 448 new positions and closed 429 in Q3 2016.
- D.E. Shaw & Co's portfolio value rose 4.5% quarter-over-quarter to $56.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2016, filed 14 Nov 2016.